ACE and chronic kidney disease: Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) have demonstrated real efficacy in reducing blood pressure and proteinuria, and in slowing the progression of chronic kidney disease (CKD) [1–3].